oral semaglutide vs injectable for Weight Loss Real-World Comparison of Oral Versus
Description
[DOI] [PubMed] [Google Scholar] 87.Perkovic V, et al
[1] [2] The European Medicines Agency's European Public Assessment Report (EPAR) for Ozempic does not specifically highlight dysgeusia as a common adverse event in clinical trials
Petrilli AA, Souza SJ, Teixeira AM, Pontilho PM, Souza JM, Luzia LA, et al
Eliaschewitz, F
